Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
BCAM/CD239 Antibody (BRIC221), Janelia Fluor™ 646, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB10066523JF646
Description
BCAM/CD239 Monoclonal specifically detects BCAM/CD239 in Human, Porcine samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen.Specifications
BCAM/CD239 | |
Monoclonal | |
Janelia Fluor 646 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
BCAM | |
Human erythrocytes | |
0.1 mL | |
4059 | |
Human, Pig | |
Purified |
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunohistochemistry (Frozen) | |
BRIC221 | |
Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen | |
antigen identified by monoclonal F8, Auberger B antigen, basal cell adhesion molecule, basal cell adhesion molecule (Lu and Au blood groups), basal cell adhesion molecule (Lutheran blood group), B-CAM cell surface glycoprotein, B-cell adhesion molecule, CD239, CD239 antigen, F8/G253 antigen, glycoprotein 95kDa, LUAU, Lutheran antigen, Lutheran blood group (Auberger b antigen included), Lutheran blood group glycoprotein, MSK19 | |
Mouse | |
Protein G purified | |
Primary | |
NB100-66523 recognizes a non-polymorphic determinant on both the 85 and 78kD Lutheran (Lu) glycoproteins. BRIC 221 specifically recognizes an epitope in the fourth extracellular domain of Lu glycoprotein. Lutheran glycoprotein is a member of the immunoglobulin superfamily and has recently been designated CD239 (B-CAM) at the 7th leucocyte typing workshop. CD239 is expressed by erythrocytes in the peripheral blood. | |
Store at 4°C in the dark. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction